Na-Ri Oh, MD is the Executive Director of Global Commercial Strategy and Operations for Hepatitis B and Hepatitis D at Gilead Sciences. Her professional focus is on bringing life-saving medicines to patients with underserved diseases.

Na-Ri was born and raised in Germany where she earned a BS in Biochemistry and Molecular Biology from University of Hamburg and an MD from Ruprecht-Karl-University of Heidelberg, Germany’s oldest university. She was also a Visiting Undergraduate at Harvard University.

Before joining the pharmaceutical industry, she practiced medicine as an Infectious Disease physician with a focus on HIV.